King's College London

Research portal

How genetic variation affects patient response and outcome to therapy for psoriasis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)957-66
Number of pages10
JournalExpert Review Of Clinical Immunology
Volume6
Issue number6
DOIs
Publication statusPublished - Nov 2010

King's Authors

Abstract

Psoriasis is a prevalent chronic inflammatory condition that affects the skin. There are many treatments available for psoriasis but they are not universally effective and some have associated toxicities. Pharmacogenetics and pharmacogenomics explore the relationship between individual genetic variation and drug effect to allow targeted 'personalized' therapy for patients. There has been very limited pharmacogenetic research regarding psoriasis, with most limited to small retrospective case-control studies looking at single-nucleotide polymorphisms in candidate genes involved in drug pharmacokinetics. We review the pharmacogenetic investigation of treatments for psoriasis to date, including emerging pharmacogenomic studies. In addition, we discuss how such genetic data could be incorporated into routine clinical practice and future areas for development in this field.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454